Evidence map›Paper›PMID 35540499›Full record

ArticleRSC advances2018

1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation.

Dongamanti Ashok, Pamula Chiranjeevi, Aamate Vikas Kumar, Madderla Sarasija, Vagolu Siva Krishna, Dharmarajan Sriram, Sridhar Balasubramanian

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Dongamanti AshokGreen and Medicinal Chemistry Lab, Department of Chemistry, Osmania University Hyderabad-500 007 Telangana State India ashokdou@gmail.com.ORCID https://orcid.org/0000-0003-4703-9554
Pamula ChiranjeeviGreen and Medicinal Chemistry Lab, Department of Chemistry, Osmania University Hyderabad-500 007 Telangana State India ashokdou@gmail.com.
Aamate Vikas KumarGreen and Medicinal Chemistry Lab, Department of Chemistry, Osmania University Hyderabad-500 007 Telangana State India ashokdou@gmail.com.
Madderla SarasijaDepartment of Chemistry, Satavahana University Karimnagar-505001 Telangana State India.
Vagolu Siva KrishnaDepartment of Pharmacy, Birla Institute of Technology & Science - Pilani Hyderabad Campus, Jawahar Nagar Hyderabad-500 078 Telangana State India.
Dharmarajan SriramDepartment of Pharmacy, Birla Institute of Technology & Science - Pilani Hyderabad Campus, Jawahar Nagar Hyderabad-500 078 Telangana State India.
Sridhar BalasubramanianX-ray Crystallography Division, CSIR-Indian Institute of Chemical Technology Hyderabad-500 007 India.
University of Hyderabad · INSatavahana University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A facile and convenient approach has been designed for the synthesis of novel prototypes that possess the advantage of the two pharmacophores of chromene and 1,2,3-triazole in a single molecular backbone, were evaluated against

Identifiers

PMID35540499
PMCPMC9080333
OpenAlexW2801907195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.